아케비아 테라퓨틱스(Akebia Therapeutics, Inc.)
US ˙ NasdaqCM ˙ US00972D1054

SecurityAKBA / Akebia Therapeutics, Inc.
InstitutionGroup One Trading, L.p.
Latest Disclosed Ownership0 shares
Latest Disclosed Value $ 0
Group One Trading, L.p. ownership in AKBA / Akebia Therapeutics, Inc.

On May 13, 2026 - Group One Trading, L.p. filed a 13F-HR form disclosing ownership of 0 shares of Akebia Therapeutics, Inc. (US:AKBA) valued at $0 USD as of March 31, 2026. The entity filed a previous 13F-HR on February 11, 2026 disclosing 133,039 shares of Akebia Therapeutics, Inc.. This represents a change in shares of -100.00% during the quarter. The current value of the position is $0 USD.

Group One Trading, L.p. has a history of taking positions in derivatives of the underlying security (AKBA) in the form of stock options. The firm currently holds call options representing 0 of underlying shares valued at $0 USD and put options representing 0 of underlying shares valued at $0 USD .

Note: prior versions of this page mistakenly stated that the share values represented the number of options, not the number of underlying shares. For more information on the data backing these reports, please see the SEC document Frequently Asked Questions About Form 13F.

Institutional Ownership: 13F and NPORT Filings

The Security and Class in the table below are shown exactly as filed by the investor. We do our best to track continuity of investments through acquisitions, and this will be reflected in the table as changes in names. In addition to descriptive data, performance of the investment is shown over time. To calculate quarterly performance, we first calculate cost basis of the shares purchased during the quarter, then use that to calculate gross profit. Quarterly return is Gross Profit / Starting Portfolio value.

Note that cost basis is calculated and stored in thousands, so small quarterly changes in shares frequently result in a cost basis of zero.

Upgrade to unlock premium data and export to Excel .

Institutional Put/Call Ratios
(Premium Subscription Required)

In addition to reporting standard equity and debt issues, institutions with more than 100MM assets under management must also disclose their put and call option holdings. Since put options generally indicate negative sentiment, and call options indicate positive sentiment, we can get a sense of the overall institutional sentiment by plotting the ratio of puts to calls. The chart to the right plots the historical put/call ratio for this instrument.

Using Put/Call Ratio as an indicator of investor sentiment overcomes one of the key deficiencies of using total institutional ownership, which is that a significant amount of assets under management are invested passively to track indices. Passively-managed funds do not typically buy options, so the put/call ratio indicator more closely tracks the sentiment of actively-managed funds.

AKBA / Akebia Therapeutics, Inc. Historical Put/Call Ratio
Disclosed Equity Positions (from 13F/NPORT Filings)
File
Date
Effective
Date
Form Security Class ID Avg Price
Paid (Est)
Reported
Shares
ΔShares ΔShares
(%)
Reported
Value
(x1000)
ΔValue
(%)
Alloc
(%)
ΔAlloc ΔAlloc (%) Cost Basis
(x1000)
Unrealized
Gain/Loss
(x1000)
2026-05-13 2026-03-31 13F AKEBIA THERAPEUTICS COM 00972D105 0 -133,039 -100.00 0 -100.00
2026-02-11 2025-12-31 13F AKEBIA THERAPEUTICS COM 00972D105 133,039 133,039 214 0.0004
2025-05-14 2024-12-31 13F/A-1 AKEBIA THERAPEUTICS COM 00972D105 0 -12,306 -100.00 0 -100.00
2025-02-14 2024-12-31 13F AKEBIA THERAPEUTICS COM 00972D105 0 -12,306 0
2024-11-14 2024-09-30 13F AKEBIA THERAPEUTICS COM 00972D105 12,306 12,306 16 0.0000
2024-08-14 2024-06-30 13F AKEBIA THERAPEUTICS COM 00972D105 0 -20,678 -100.00 0 -100.00
2024-05-10 2024-03-31 13F AKEBIA THERAPEUTICS COM 00972D105 20,678 -29,029 -58.40 38 -39.34 0.0001
2024-02-14 2023-12-31 13F AKEBIA THERAPEUTICS COM 00972D105 49,707 -38,694 -43.77 62 -39.00 0.0002
2023-11-09 2023-09-30 13F AKEBIA THERAPEUTICS COM 00972D105 88,401 -78,801 -47.13 101 -34.21 0.0003
2023-08-09 2023-06-30 13F AKEBIA THERAPEUTICS COM 00972D105 167,202 -98,065 -36.97 153 2.70 0.0005
2023-05-12 2023-03-31 13F AKEBIA THERAPEUTICS COM 00972D105 265,267 -106,771 -28.70 149 -30.84 0.0005
2023-02-09 2022-12-31 13F AKEBIA THERAPEUTICS COM 00972D105 372,038 -40,675 -9.86 215 63.36 0.0005
2022-11-09 2022-09-30 13F AKEBIA THERAPEUTICS COM 00972D105 412,713 -55,251 -11.81 131 -20.61 0.0003
2022-08-11 2022-06-30 13F AKEBIA THERAPEUTICS COM 00972D105 467,964 65,780 16.36 165 -42.91 0.0003
2022-05-12 2022-03-31 13F AKEBIA THERAPEUTICS COM 00972D105 402,184 336,783 514.95 289 95.27 0.0003
2022-02-11 2021-12-31 13F AKEBIA THERAPEUTICS COM 00972D105 65,401 44,568 213.93 148 146.67 0.0001
2021-11-12 2021-09-30 13F AKEBIA THERAPEUTICS COM 00972D105 20,833 3,469 19.98 60 -9.09 0.0001
2021-08-10 2021-06-30 13F AKEBIA THERAPEUTICS COM 00972D105 17,364 -36,028 -67.48 66 -63.54 0.0001
2021-05-12 2021-03-31 13F AKEBIA THERAPEUTICS COM 00972D105 53,392 -41,272 -43.60 181 -31.70 0.0003
2021-02-10 2020-12-31 13F AKEBIA THERAPEUTICS COM 00972D105 94,664 60,084 173.75 265 204.60 0.0005
2020-11-12 2020-09-30 13F AKEBIA THERAPEUTICS COM 00972D105 34,580 34,580 87 0.0003
2020-08-13 2020-06-30 13F AKEBIA THERAPEUTICS COM 00972D105 0 -83,972 -100.00 0 -100.00
2020-05-13 2020-03-31 13F AKEBIA THERAPEUTICS COM 00972D105 83,972 19,930 31.12 637 57.28 0.0052
2020-02-10 2019-12-31 13F AKEBIA THERAPEUTICS COM 00972D105 64,042 -4,010 -5.89 405 51.69 0.0028
2019-11-12 2019-09-30 13F AKEBIA THERAPEUTICS COM 00972D105 68,052 -2,025 -2.89 267 -21.24 0.0022
2019-08-09 2019-06-30 13F AKEBIA THERAPEUTICS COM 00972D105 70,077 70,077 339 0.0031
2019-05-14 2019-03-31 13F/A-1 AKEBIA THERAPEUTICS COM 00972D105 0 -8,142 -100.00 0 -100.00
2019-02-05 2018-12-31 13F AKEBIA THERAPEUTICS COM 00972D105 8,142 -4,906 -37.60 45 -60.87 0.0004
2018-11-08 2018-09-30 13F AKEBIA THERAPEUTICS COM 00972D105 13,048 1,300 11.07 115 -1.71 0.0009
2018-08-13 2018-06-30 13F AKEBIA THERAPEUTICS COM 00972D105 11,748 11,748 117 0.0010
2018-02-09 2017-12-31 13F AKEBIA THERAPEUTICS COM 00972D105 0 -5,713 -100.00 0 -100.00
2017-11-15 2017-09-30 13F AKEBIA THERAPEUTICS COM 00972D105 5,713 5,713 112 0.0010
2017-08-14 2017-06-30 13F AKEBIA THERAPEUTICS COM 00972D105 0 -25,662 -100.00 0 -100.00
2017-05-10 2017-03-31 13F AKEBIA THERAPEUTICS COM 00972D105 25,662 14,211 124.10 236 98.32 0.0027
2017-02-15 2016-12-31 13F AKEBIA THERAPEUTICS COM 00972D105 11,451 -18,440 -61.69 119 -56.09 0.0012
2016-11-14 2016-09-30 13F AKEBIA THERAPEUTICS COM 00972D105 29,891 5,389 21.99 271 48.09 0.0029
2016-08-12 2016-06-30 13F AKEBIA THERAPEUTICS COM 00972D105 24,502 7,226 41.83 183 17.31 0.0022
2016-05-12 2016-03-31 13F AKEBIA THERAPEUTICS COM 00972D105 17,276 10,040 138.75 156 67.74 0.0022
2016-02-11 2015-12-31 13F AKEBIA THERAPEUTICS COM 00972D105 7,236 -5,828 -44.61 93 -26.19 0.0011
2015-11-20 2015-09-30 13F/A-1 AKEBIA THERAPEUTICS COM 00972D105 13,064 4,311 49.25 126 40.00 0.0017
2015-11-06 2015-09-30 13F AKEBIA THERAPEUTICS COM 00972D105 13,064 126
2015-08-11 2015-06-30 13F AKEBIA THERAPEUTICS COM 00972D105 8,753 -4,022 -31.48 90 -36.62 0.0013
2015-05-14 2015-03-31 13F AKEBIA THERAPEUTICS COM 00972D105 12,775 1,397 12.28 142 7.58 0.0022
2015-02-11 2014-12-31 13F AKEBIA THERAPEUTICS COM 00972D105 11,378 11,142 4,721.19 132 2,540.00 0.0020
2014-10-31 2014-09-30 13F AKEBIA THERAPEUTICS COM 00972D105 236 236 5 0.0001
Disclosed Call Options
File
Date
Effective
Date
Form Security Class ID Opt Avg Share
Price
Shares ΔShares
(%)
Value
(x1000)
ΔValue
(%)
Prior Allocation
(%)
Allocation
(%)
ΔAllocation
(%)
Cost Basis
(x1000)
Profit
(x1000)
Return
(%)
2026-05-13 2026-03-31 13F AKEBIA THERAPEUTICS COM Call 0 -100.00 0 -100.00 n/a n/a n/a
2026-02-11 2025-12-31 13F AKEBIA THERAPEUTICS COM Call 102,000 -71.68 164 -83.32 n/a n/a n/a
2025-11-12 2025-09-30 13F AKEBIA THERAPEUTICS COM Call 360,200 -1.13 983 -25.87 n/a n/a n/a
2025-08-14 2025-06-30 13F AKEBIA THERAPEUTICS COM Call 364,300 53.84 1,326 192.07 n/a n/a n/a
2025-05-14 2025-03-31 13F AKEBIA THERAPEUTICS COM Call 236,800 199.37 455 202.67 n/a n/a n/a
2025-05-14 2024-12-31 13F/A AKEBIA THERAPEUTICS COM Call 79,100 -29.25 150 2.04 n/a n/a n/a
2025-02-14 2024-12-31 13F AKEBIA THERAPEUTICS COM Call 79,100 150 n/a n/a n/a
2024-11-14 2024-09-30 13F AKEBIA THERAPEUTICS COM Call 111,800 -39.50 148 -21.81 n/a n/a n/a
2024-08-14 2024-06-30 13F AKEBIA THERAPEUTICS COM Call 184,800 -16.91 188 -53.69 n/a n/a n/a
2024-05-10 2024-03-31 13F AKEBIA THERAPEUTICS COM Call 222,400 -55.72 407 -34.73 n/a n/a n/a
2024-02-14 2023-12-31 13F AKEBIA THERAPEUTICS COM Call 502,300 -27.36 623 -21.07 n/a n/a n/a
2023-11-09 2023-09-30 13F AKEBIA THERAPEUTICS COM Call 691,500 81.40 788 126.44 n/a n/a n/a
2023-08-09 2023-06-30 13F AKEBIA THERAPEUTICS COM Call 381,200 46.33 349 140.00 n/a n/a n/a
2023-05-12 2023-03-31 13F AKEBIA THERAPEUTICS COM Call 260,500 327.75 146 314.29 n/a n/a n/a
2023-02-09 2022-12-31 13F AKEBIA THERAPEUTICS COM Call 60,900 -62.03 35 -31.37 n/a n/a n/a
2022-11-09 2022-09-30 13F AKEBIA THERAPEUTICS COM Call 160,400 98.02 51 75.86 n/a n/a n/a
2022-08-11 2022-06-30 13F AKEBIA THERAPEUTICS COM Call 81,000 -66.74 29 -83.43 n/a n/a n/a
2022-05-12 2022-03-31 13F AKEBIA THERAPEUTICS COM Call 243,500 -7.34 175 -70.54 n/a n/a n/a
2022-02-11 2021-12-31 13F AKEBIA THERAPEUTICS COM Call 262,800 66.01 594 30.26 n/a n/a n/a
2021-11-12 2021-09-30 13F AKEBIA THERAPEUTICS COM Call 158,300 90.04 456 44.30 n/a n/a n/a
2021-08-10 2021-06-30 13F AKEBIA THERAPEUTICS COM Call 83,300 -44.02 316 -37.30 n/a n/a n/a
2021-05-12 2021-03-31 13F AKEBIA THERAPEUTICS COM Call 148,800 -38.21 504 -25.22 n/a n/a n/a
2021-02-10 2020-12-31 13F AKEBIA THERAPEUTICS COM Call 240,800 -53.90 674 -48.59 n/a n/a n/a
2020-11-12 2020-09-30 13F AKEBIA THERAPEUTICS COM Call 522,300 170.90 1,311 -49.92 n/a n/a n/a
2020-08-13 2020-06-30 13F AKEBIA THERAPEUTICS COM Call 192,800 515.97 2,618 1,004.64 n/a n/a n/a
2020-05-13 2020-03-31 13F AKEBIA THERAPEUTICS COM Call 31,300 -60.13 237 -52.22 n/a n/a n/a
2020-02-10 2019-12-31 13F AKEBIA THERAPEUTICS COM Call 78,500 15,600.00 496 24,700.00 n/a n/a n/a
2019-11-12 2019-09-30 13F AKEBIA THERAPEUTICS COM Call 500 -75.00 2 -80.00 n/a n/a n/a
2019-08-09 2019-06-30 13F AKEBIA THERAPEUTICS COM Call 2,000 -71.43 10 -82.46 n/a n/a n/a
2019-05-14 2019-03-31 13F/A AKEBIA THERAPEUTICS COM Call 7,000 -82.46 57 -74.21 n/a n/a n/a
2019-05-13 2019-03-31 13F AKEBIA THERAPEUTICS COM Call 7,000 57 n/a n/a n/a
2019-02-05 2018-12-31 13F AKEBIA THERAPEUTICS COM Call 39,900 221 n/a n/a n/a
2018-11-08 2018-09-30 13F AKEBIA THERAPEUTICS COM Call 0 -100.00 0 -100.00 n/a n/a n/a
2018-08-13 2018-06-30 13F AKEBIA THERAPEUTICS COM Call 1,400 -94.47 14 -94.19 n/a n/a n/a
2018-05-16 2018-03-31 13F/A AKEBIA THERAPEUTICS COM Call 25,300 140.95 241 54.49 n/a n/a n/a
2018-05-10 2018-03-31 13F AKEBIA THERAPEUTICS COM Call 25,300 241 n/a n/a n/a
2018-02-09 2017-12-31 13F AKEBIA THERAPEUTICS COM Call 10,500 3,400.00 156 2,500.00 n/a n/a n/a
2017-11-15 2017-09-30 13F AKEBIA THERAPEUTICS COM Call 300 -99.15 6 -98.81 n/a n/a n/a
2017-08-14 2017-06-30 13F AKEBIA THERAPEUTICS COM Call 35,200 15.79 506 80.71 n/a n/a n/a
2017-05-10 2017-03-31 13F AKEBIA THERAPEUTICS COM Call 30,400 36.32 280 20.69 n/a n/a n/a
2017-02-15 2016-12-31 13F AKEBIA THERAPEUTICS COM Call 22,300 102.73 232 132.00 n/a n/a n/a
2016-11-14 2016-09-30 13F AKEBIA THERAPEUTICS COM Call 11,000 -22.54 100 -5.66 n/a n/a n/a
2016-08-12 2016-06-30 13F AKEBIA THERAPEUTICS COM Call 14,200 -60.99 106 -67.68 n/a n/a n/a
2016-05-12 2016-03-31 13F AKEBIA THERAPEUTICS COM Call 36,400 126.09 328 57.69 n/a n/a n/a
2016-02-11 2015-12-31 13F AKEBIA THERAPEUTICS COM Call 16,100 -47.56 208 -29.97 n/a n/a n/a
2015-11-20 2015-09-30 13F/A AKEBIA THERAPEUTICS COM Call 30,700 420.34 297 386.89 n/a n/a n/a
2015-11-06 2015-09-30 13F AKEBIA THERAPEUTICS COM Call 30,700 297 n/a n/a n/a
2015-08-11 2015-06-30 13F AKEBIA THERAPEUTICS COM Call 5,900 7.27 61 0.00 n/a n/a n/a
2015-05-14 2015-03-31 13F AKEBIA THERAPEUTICS COM Call 5,500 77.42 61 69.44 n/a n/a n/a
2015-02-11 2014-12-31 13F AKEBIA THERAPEUTICS COM Call 3,100 -52.31 36 -75.00 n/a n/a n/a
2014-10-31 2014-09-30 13F AKEBIA THERAPEUTICS COM Call 6,500 144 n/a n/a n/a
Disclosed Put Options
File
Date
Effective
Date
Form Security Class ID Opt Avg Share Price Shares ΔShares
(%)
Value
(x1000)
ΔValue
(%)
Prior Allocation
(%)
Allocation
(%)
ΔAllocation
(%)
Cost Basis
(x1000)
Profit
(x1000)
Return
(%)
2026-05-13 2026-03-31 13F AKEBIA THERAPEUTICS COM Put 0 -100.00 0 -100.00 n/a n/a n/a
2026-02-11 2025-12-31 13F AKEBIA THERAPEUTICS COM Put 25,200 -59.09 41 -76.19 n/a n/a n/a
2025-11-12 2025-09-30 13F AKEBIA THERAPEUTICS COM Put 61,600 -0.32 168 -25.00 n/a n/a n/a
2025-08-14 2025-06-30 13F AKEBIA THERAPEUTICS COM Put 61,800 -41.20 225 11.44 n/a n/a n/a
2025-05-14 2025-03-31 13F AKEBIA THERAPEUTICS COM Put 105,100 56.40 202 58.27 n/a n/a n/a
2025-05-14 2024-12-31 13F/A AKEBIA THERAPEUTICS COM Put 67,200 -56.28 128 -37.13 n/a n/a n/a
2025-02-14 2024-12-31 13F AKEBIA THERAPEUTICS COM Put 67,200 128 n/a n/a n/a
2024-11-14 2024-09-30 13F AKEBIA THERAPEUTICS COM Put 153,700 -2.16 203 26.25 n/a n/a n/a
2024-08-14 2024-06-30 13F AKEBIA THERAPEUTICS COM Put 157,100 16.54 160 -34.96 n/a n/a n/a
2024-05-10 2024-03-31 13F AKEBIA THERAPEUTICS COM Put 134,800 118.12 247 223.68 n/a n/a n/a
2024-02-14 2023-12-31 13F AKEBIA THERAPEUTICS COM Put 61,800 63.06 77 76.74 n/a n/a n/a
2023-11-09 2023-09-30 13F AKEBIA THERAPEUTICS COM Put 37,900 -35.10 43 -18.87 n/a n/a n/a
2023-08-09 2023-06-30 13F AKEBIA THERAPEUTICS COM Put 58,400 21.16 53 96.30 n/a n/a n/a
2023-05-12 2023-03-31 13F AKEBIA THERAPEUTICS COM Put 48,200 92.03 27 92.86 n/a n/a n/a
2023-02-09 2022-12-31 13F AKEBIA THERAPEUTICS COM Put 25,100 -40.38 14 7.69 n/a n/a n/a
2022-11-09 2022-09-30 13F AKEBIA THERAPEUTICS COM Put 42,100 -22.04 13 -31.58 n/a n/a n/a
2022-08-11 2022-06-30 13F AKEBIA THERAPEUTICS COM Put 54,000 -76.54 19 -88.48 n/a n/a n/a
2022-05-12 2022-03-31 13F AKEBIA THERAPEUTICS COM Put 230,200 918.58 165 223.53 n/a n/a n/a
2022-02-11 2021-12-31 13F AKEBIA THERAPEUTICS COM Put 22,600 -72.57 51 -78.48 n/a n/a n/a
2021-11-12 2021-09-30 13F AKEBIA THERAPEUTICS COM Put 82,400 -37.29 237 -52.41 n/a n/a n/a
2021-08-10 2021-06-30 13F AKEBIA THERAPEUTICS COM Put 131,400 18.81 498 33.16 n/a n/a n/a
2021-05-12 2021-03-31 13F AKEBIA THERAPEUTICS COM Put 110,600 2,357.78 374 2,776.92 n/a n/a n/a
2021-02-10 2020-12-31 13F AKEBIA THERAPEUTICS COM Put 4,500 -83.52 13 -81.16 n/a n/a n/a
2020-11-12 2020-09-30 13F AKEBIA THERAPEUTICS COM Put 27,300 -24.38 69 -85.92 n/a n/a n/a
2020-08-13 2020-06-30 13F AKEBIA THERAPEUTICS COM Put 36,100 875.68 490 1,650.00 n/a n/a n/a
2020-05-13 2020-03-31 13F AKEBIA THERAPEUTICS COM Put 3,700 -66.67 28 -60.00 n/a n/a n/a
2020-02-10 2019-12-31 13F AKEBIA THERAPEUTICS COM Put 11,100 -42.49 70 -7.89 n/a n/a n/a
2019-11-12 2019-09-30 13F AKEBIA THERAPEUTICS COM Put 19,300 9.66 76 -10.59 n/a n/a n/a
2019-08-09 2019-06-30 13F AKEBIA THERAPEUTICS COM Put 17,600 166.67 85 57.41 n/a n/a n/a
2019-05-14 2019-03-31 13F/A AKEBIA THERAPEUTICS COM Put 6,600 -81.82 54 -73.13 n/a n/a n/a
2019-05-13 2019-03-31 13F AKEBIA THERAPEUTICS COM Put 6,600 54 n/a n/a n/a
2019-02-05 2018-12-31 13F AKEBIA THERAPEUTICS COM Put 36,300 384.00 201 204.55 n/a n/a n/a
2018-11-08 2018-09-30 13F AKEBIA THERAPEUTICS COM Put 7,500 -55.62 66 -60.95 n/a n/a n/a
2018-08-13 2018-06-30 13F AKEBIA THERAPEUTICS COM Put 16,900 38.52 169 45.69 n/a n/a n/a
2018-05-16 2018-03-31 13F/A AKEBIA THERAPEUTICS COM Put 12,200 0.83 116 -35.56 n/a n/a n/a
2018-05-10 2018-03-31 13F AKEBIA THERAPEUTICS COM Put 12,200 116 n/a n/a n/a
2018-02-09 2017-12-31 13F AKEBIA THERAPEUTICS COM Put 12,100 101.67 180 52.54 n/a n/a n/a
2017-11-15 2017-09-30 13F AKEBIA THERAPEUTICS COM Put 6,000 -84.96 118 -79.41 n/a n/a n/a
2017-08-14 2017-06-30 13F AKEBIA THERAPEUTICS COM Put 39,900 101.52 573 214.84 n/a n/a n/a
2017-05-10 2017-03-31 13F AKEBIA THERAPEUTICS COM Put 19,800 -25.84 182 -34.53 n/a n/a n/a
2017-02-15 2016-12-31 13F AKEBIA THERAPEUTICS COM Put 26,700 -55.65 278 -48.99 n/a n/a n/a
2016-11-14 2016-09-30 13F AKEBIA THERAPEUTICS COM Put 60,200 38.71 545 67.69 n/a n/a n/a
2016-08-12 2016-06-30 13F AKEBIA THERAPEUTICS COM Put 43,400 -16.22 325 -30.41 n/a n/a n/a
2016-05-12 2016-03-31 13F AKEBIA THERAPEUTICS COM Put 51,800 763.33 467 498.72 n/a n/a n/a
2016-02-11 2015-12-31 13F AKEBIA THERAPEUTICS COM Put 6,000 -88.10 78 -83.98 n/a n/a n/a
2015-11-20 2015-09-30 13F/A AKEBIA THERAPEUTICS COM Put 50,400 150.75 487 135.27 n/a n/a n/a
2015-11-06 2015-09-30 13F AKEBIA THERAPEUTICS COM Put 50,400 487 n/a n/a n/a
2015-08-11 2015-06-30 13F AKEBIA THERAPEUTICS COM Put 20,100 279.25 207 250.85 n/a n/a n/a
2015-05-14 2015-03-31 13F AKEBIA THERAPEUTICS COM Put 5,300 -42.39 59 -44.86 n/a n/a n/a
2015-02-11 2014-12-31 13F AKEBIA THERAPEUTICS COM Put 9,200 53.33 107 -19.55 n/a n/a n/a
2014-10-31 2014-09-30 13F AKEBIA THERAPEUTICS COM Put 6,000 133 n/a n/a n/a
Legend
Shares
The total number of shares held by the institution at the end of the reporting period (the effective date). This is provided in the filing.
Value
The total value of the shares as of the effective date. This is provided in the filing.
Avg. Share Price
The weighted average share price of the shares held by the institution. We use FIFO accounting to determine this price
Class
This is the security class as indicated by the filer. There are a variety of values for this field. Common values include "EC" = equity common, "EP" - equity preferred
Allocation (%)
The percent of the institution's portfolio that this position represents. This is provided in NPORT filings. For 13F filings, we calculate it.
Change in Allocation
The change in allocation from the prior reporting period. This is calculated as current allocation - prior allocation.
Change in Allocation (%)
The percent change in allocation from the prior reporting period. This is calculated as (current allocation - prior allocation) / prior allocation.
Cost Basis
The total cost of the shares held. This is calculated as reported shares * avg. share price
Unrealized Gain/Loss
This is the market value of the position as of the effective date minus the cost basis.